Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADORA2A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | MYO1G | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | AC141272.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | FNDC5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SERTM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CLIC6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | NCOA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | VSX2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PDIA6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | DGKE | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |